These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 5695503

  • 1. Utilization of the residual plasma following preparation of factor VIII cryoprecipitate.
    Oberman HA, Penner JA.
    JAMA; 1968 Sep 16; 205(12):819-21. PubMed ID: 5695503
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of congenital deficiencies of factor VIII and factor IX.
    Rizza CR, Biggs R.
    Thromb Diath Haemorrh Suppl; 1968 Sep 16; 35():73-84. PubMed ID: 5317365
    [No Abstract] [Full Text] [Related]

  • 3. Cryoprecipitate and the plastic blood-bag system: provision of adequate replacement therapy for routine treatment of haemophilia.
    Bennett E, Dormandy KM, Churchill WG, Coward AR, Smith M, Cleghorn TE.
    Br Med J; 1967 Apr 08; 2(5544):88-91. PubMed ID: 6020855
    [No Abstract] [Full Text] [Related]

  • 4. Concentrated antihemophilic factor (AHF) from outdated blood.
    Weaver RA, Gabriel DA, Langdell RD.
    Transfusion; 1967 Apr 08; 7(3):168-73. PubMed ID: 6025692
    [No Abstract] [Full Text] [Related]

  • 5. Preparation of pooled cryoprecipitate for treatment of hemophilia A in a home care program.
    Smith KJ, Hodges PA.
    Transfusion; 1984 Apr 08; 24(6):520-3. PubMed ID: 6438840
    [Abstract] [Full Text] [Related]

  • 6. [Transfusion therapy of hemophilia A and B].
    Egli H.
    Bibl Haematol; 1967 Apr 08; 27():204-10. PubMed ID: 5595089
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fractions rich in factor VIII.
    Biggs R.
    Bibl Haematol; 1968 Apr 08; 29():1122-6. PubMed ID: 5750137
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of haemorrhages in a haemophiliac with factor-VIII inhibitor (author's transl)].
    Angelkort B, Stürner KH.
    Dtsch Med Wochenschr; 1979 Feb 02; 104(5):182-6. PubMed ID: 759178
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cryoprecipitate in the management of haemophilia in Kenya.
    Taylor JR, Ahluwalia NS, Morrison CJ, Kaviti JN, Cardwell CL.
    East Afr Med J; 1969 Feb 02; 46(2):121-8. PubMed ID: 5798053
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Production of high-potency cryoprecipitate from exercised blood donors and the treatment of hemophilia A with this material.
    Strand CL, Beene JR, Geiger T, Eckel MO, Kunkel K, Bull G.
    Am J Clin Pathol; 1974 Oct 02; 62(4):496-501. PubMed ID: 4415312
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Therapy for AHF and PTC hemophilia. I.
    Seeler RA.
    IMJ Ill Med J; 1970 May 02; 137(5):518-21. PubMed ID: 4392774
    [No Abstract] [Full Text] [Related]

  • 20. Storage of whole blood for up to 24 hours at ambient temperature before component preparation: implementation in the Netherlands.
    Pietersz RN.
    Transfusion; 2011 Jan 02; 51 Suppl 1():3S-6S. PubMed ID: 21223289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.